| scholarly article | Q13442814 |
| P2093 | author name string | C E F Starling | |
| J A G Ferreira | |||
| J H Carr | |||
| M A de Resende | |||
| R M Donlan | |||
| P2860 | cites work | Biofilms: survival mechanisms of clinically relevant microorganisms | Q22299328 |
| Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin | Q24674839 | ||
| Echinocandins: a new class of antifungal | Q28201851 | ||
| Persister cells, dormancy and infectious disease | Q29615655 | ||
| Epidemiology of invasive candidiasis: a persistent public health problem | Q29616758 | ||
| Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. | Q30452376 | ||
| Biofilm formation by Candida dubliniensis | Q30705127 | ||
| Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces | Q30799502 | ||
| Candida biofilms: antifungal resistance and emerging therapeutic options. | Q30829656 | ||
| Antifungal resistance of candidal biofilms formed on denture acrylic in vitro | Q43622404 | ||
| Attributable mortality of nosocomial candidemia, revisited | Q44386169 | ||
| Medical importance of biofilms in Candida infections. | Q44490927 | ||
| Nosocomial bloodstream infections in United States hospitals: a three-year analysis | Q44863798 | ||
| Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms | Q46616041 | ||
| In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth | Q46648323 | ||
| Role of dimorphism in the development of Candida albicans biofilms. | Q53928861 | ||
| Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. | Q54037537 | ||
| Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System | Q64128267 | ||
| Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model | Q80082574 | ||
| Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins | Q31058690 | ||
| In vitro activity of caspofungin against Candida albicans biofilms. | Q31114513 | ||
| Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors | Q31936121 | ||
| Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast [...] | Q33667850 | ||
| Biofilm, city of microbes | Q33899018 | ||
| Candida biofilms | Q34161590 | ||
| Biofilms and device-associated infections | Q34213700 | ||
| Biofilms of Candida albicans and their associated resistance to antifungal agents. | Q34379989 | ||
| The antibiotic-lock technique for therapy of 'highly needed' infected catheters | Q34669360 | ||
| Resistance of Candida albicans biofilms to antifungal agents in vitro | Q35118735 | ||
| Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols | Q35164903 | ||
| The global epidemiology of invasive Candida infections--is the tide turning? | Q35565563 | ||
| Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. | Q35635952 | ||
| Candida infections of medical devices | Q35745818 | ||
| Role for cell density in antifungal drug resistance in Candida albicans biofilms | Q35878982 | ||
| Candida biofilm resistance | Q35943395 | ||
| Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species | Q36094887 | ||
| How to build a biofilm: a fungal perspective | Q36630762 | ||
| A comparative evaluation of properties and clinical efficacy of the echinocandins | Q36895839 | ||
| Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect. | Q36987908 | ||
| Update on echinocandin antifungals | Q37118866 | ||
| Molecular mechanisms of mechanosensing and their roles in fungal contact sensing | Q37234988 | ||
| Biofilm lifestyle of Candida: a mini review. | Q37348653 | ||
| Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. | Q37523933 | ||
| Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli | Q37663571 | ||
| Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy | Q37734765 | ||
| Candida albicans biofilms produce antifungal-tolerant persister cells | Q39077924 | ||
| Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. | Q39558196 | ||
| In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. | Q39657947 | ||
| Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection | Q39789893 | ||
| Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations | Q39954432 | ||
| Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole | Q39954846 | ||
| Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms | Q41912237 | ||
| Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms. | Q42111899 | ||
| Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms | Q43415980 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biofilm | Q467410 |
| Candida | Q131260 | ||
| P304 | page(s) | 4377-4384 | |
| P577 | publication date | 2009-06-22 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates | |
| P478 | volume | 53 |
| Q54581534 | A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms. |
| Q35218859 | Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms |
| Q58576582 | Antifungal Susceptibility and Biofilm Production of spp. Isolated from Clinical Samples |
| Q41615060 | Application of lyophilization to prepare the nitrifying bacterial biofilm for imaging with scanning electron microscopy. |
| Q42202185 | Bacteriophage K antimicrobial-lock technique for treatment of Staphylococcus aureus central venous catheter-related infection: a leporine model efficacy analysis |
| Q41953340 | Bacteriophage K for reduction of Staphylococcus aureusbiofilm on central venous catheter material |
| Q35941017 | Biofilm Filtrates of Pseudomonas aeruginosa Strains Isolated from Cystic Fibrosis Patients Inhibit Preformed Aspergillus fumigatus Biofilms via Apoptosis |
| Q53797724 | Biofilm production and antifungal susceptibility of co-cultured Malassezia pachydermatis and Candida parapsilosis isolated from canine seborrheic dermatitis. |
| Q40441491 | Biological control of biofilms on membranes by metazoans |
| Q46501464 | Candida tropicalis from veterinary and human sources shows similar in vitro hemolytic activity, antifungal biofilm susceptibility and pathogenesis against Caenorhabditis elegans |
| Q91971465 | Cefepime and Amoxicillin Increase Metabolism and Enhance Caspofungin Tolerance of Candida albicans Biofilms |
| Q37554055 | Current perspectives on echinocandin class drugs |
| Q38254290 | Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management |
| Q39413837 | Experimental biofilm-related Candida infections |
| Q35791192 | In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis |
| Q52641213 | In vitro antibacterial effects of statins against bacterial pathogens causing skin infections. |
| Q84434680 | In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms |
| Q42709505 | In vitro effectiveness of anidulafungin against Candida sp. biofilms |
| Q34368983 | In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms |
| Q35739749 | Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the Bacterium |
| Q38550402 | Mechanisms of echinocandin antifungal drug resistance |
| Q34057572 | Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms |
| Q39173771 | Micafungin is more active against Candida albicans biofilms with high metabolic activity |
| Q39977764 | Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates. |
| Q30570494 | Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence |
| Q49679966 | Recent Insights into the Paradoxical Effect of Echinocandins |
| Q37026730 | Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates |
| Q28547086 | Synergistic Activity of the Plant Defensin HsAFP1 and Caspofungin against Candida albicans Biofilms and Planktonic Cultures |
| Q33798459 | Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms |
| Q36683547 | The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia |
Search more.